Not yet recruiting
Execution of Prehospital Transesophageal Echocardiography During Cardiopulmonary Resuscitation in Patients With Out-of-hospital Cardiac Arrest
NCT07909642· Far Eastern Memorial Hospital· Source
Contact: Sheng-En Chu, Physician
Not yet recruiting
An Observational Study of LEQEMBI in Routine Clinical Practice in Taiwan
NCT07869264· Eisai Taiwan Inc.· Source
Recruiting
The Effects of Wintergreen Essential Oil Inhalation on Alleviating Dyspnea Among Patients With Pneumonia
NCT07894835· Far Eastern Memorial Hospital· Source
Contact: Shu-Ding Lin
Not yet recruiting
Efficacy and Safety of Super High-Flux Hemodialysis in Maintenance Dialysis Patients. SHINE-RLS (Super High-flux Dialysis Improves Neuro-symptoms and Efficacy in Restless Legs Syndrome)
NCT07794826· Far Eastern Memorial Hospital· Source
Contact: Wan-Chuan Tsai, M.D., Ph.D.
Recruiting
Safety and Preliminary Effectiveness Study of Mesenchymal Stem Cells, HeXell-2020, in Patients With Stable Coronary Artery Disease
NCT07137104· Phase 1/2· Hexun Biosciences Co., LTD.· Source
Contact: Wannhsin Chen
Not yet recruiting
A Clinical Trial Assessing the Efficacy and Safety of ST-1 Silicone Hydrogel Daily Disposable Soft Contact Lenses Compared to Miru 1day UpSide
NCT07345416· Menicon Co., Ltd.· Source
Contact: Tzu-Yun Tsai
Recruiting
A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)
NCT07361497· Phase 3· Bristol-Myers Squibb· Source
Contact: Cheng-Yu Chang, Site 0729
Recruiting
A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)
NCT07361510· Phase 3· Bristol-Myers Squibb· Source
Contact: Cheng-Yu Chang, Site 0035
Recruiting
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
NCT07363694· Phase 2/3· Pfizer· Source
Not yet recruiting
The Role of Blood Perfusion in Cervical Cancer, Cervical Intraepithelial Neoplasm and Ovarian Cancer Patients
NCT07385976· Far Eastern Memorial Hospital· Source
Contact: Sheng-Mou Hsiao, MD
Recruiting
Study to Evaluate the Efficacy, Safety, and Tolerability of PIPE 791 in Subjects With Idiopathic Pulmonary Fibrosis
NCT07284459· Phase 2· Contineum Therapeutics· Source
Contact: Nikki Nepomuceno
Recruiting
A Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease (ATTAIN-Outcomes)
NCT07241390· Phase 3· Eli Lilly and Company· Source
Contact: Yu-Sen Peng (principal investigator)
Recruiting
Exploring Efficacy of Multi-Mode Cognitive Processing Therapy (CPT) for PTSD
NCT07105345· Far Eastern Memorial Hospital· Source
Contact: Hsin-I Liu, PhD, RN
Recruiting
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
NCT07064473· Phase 3· Boehringer Ingelheim· Source
Contact: Boehringer Ingelheim
Recruiting
Exploring the Feasibility of Transcranial Ultrasound Stimulation in the Treatment of Schizophrenia
NCT07621549· Far Eastern Memorial Hospital· Source
Contact: Yi-Ju Pan, Ph. D.
Recruiting
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma
NCT06977581· Phase 2· Pfizer· Source
Recruiting
A Study to Learn About the Effects of Felzartamab Infusions on Adults With Immunoglobulin A Nephropathy (IgAN)
NCT06935357· Phase 3· Biogen· Source
Contact: US Biogen Clinical Trial Center
Active, not recruiting
Effect of Dialysis-specific Therapeutic Diet on Biochemical Parameters in Dialysis Patients
NCT06377293· Far Eastern Memorial Hospital· Source
Recruiting
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
NCT06890598· Phase 3· Eli Lilly and Company· Source
Contact: Cheng-Yu Chang (principal investigator)
Active, not recruiting
A Trial to Evaluate Efficacy and Safety of Buloxibutid in People With Idiopathic Pulmonary Fibrosis.
NCT06588686· Phase 2· Vicore Pharma AB· Source
Active, not recruiting
ATTR-CM: A Multi-country, Non-interventional Disease Registry
NCT06651073· Pfizer· Source
Active, not recruiting
EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)
NCT06531824· Phase 3· Boehringer Ingelheim· Source
Active, not recruiting
Clinical Performance Evaluation of RDX-Aneurysm for Detecting Intracranial Aneurysms on TOF-MRA
NCT07655635· Taipei Medical University Shuang Ho Hospital· Source
Recruiting
A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease
NCT06226883· Phase 2· Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)· Source
Contact: Chen-Shuan Chung (principal investigator)
Recruiting
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
NCT05485961· Phase 2/3· CSL Behring· Source
Contact: Trial Registration Coordinator
Active, not recruiting
Transmural Healing and Disease-Modifying Effect of Guselkumab in Crohn's Disease Patients
NCT06408935· Phase 3· Janssen-Cilag Ltd.· Source
Recruiting
A Phase 3 Study of Efepoetin Alfa for Treatment of Anemia in Patients With Chronic Kidney Disease on Dialysis
NCT06466785· Phase 3· Genexine, Inc.· Source
Contact: Yu-Sen Peng, MD
Recruiting
Short Course Regimen in Low Risk Active Tuberculosis- a Multicenter, Randomized, Active-controlled, Trial
NCT06727864· Phase 3· Kaohsiung Veterans General Hospital.· Source
Contact: Wang Ping-Huai PhD, PhD
Recruiting
MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)
NCT06128629· Phase 3· Intellia Therapeutics· Source
Contact: Trial Manager at Intellia
Active, not recruiting
Drug-Coated Balloon vs. Drug-Eluting Stent for Clinical Outcomes in Patients With Large Coronary Artery Disease
NCT05846893· B. Braun Medical Industries Sdn. Bhd.· Source
Active, not recruiting
A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation
NCT05757869· Phase 3· Janssen Research & Development, LLC· Source
Recruiting
Taiwan Registry of Hypertrophic Cardiomyopathy (THIC) Research Synopsis
NCT06381778· Far Eastern Memorial Hospital· Source
Contact: Yen-Wen Wu, MD, PhD
Active, not recruiting
A Research Study to Evaluate the Effects of a New Oral Medicine Called Cenerimod in Adults With Systemic Lupus Erythematosus
NCT05648500· Phase 3· Viatris Innovation GmbH· Source
Recruiting
A Multi-center Cardiac PYP Scan Registry in Taiwan
NCT05593679· Far Eastern Memorial Hospital· Source
Contact: Yen-Wen Wu, MD, PhD
Active, not recruiting
A Study of Tirzepatide (LY3298176) on the Reduction on Morbidity and Mortality in Adults With Obesity
NCT05556512· Phase 3· Eli Lilly and Company· Source
Enrolling by invitation
Extension Study of Inhaled Treprostinil in Subjects With Fibrotic Lung Disease
NCT04905693· Phase 3· United Therapeutics· Source
Active, not recruiting
COMBINE-INTERVENE: COMBINEd Ischemia and Vulnerable Plaque Percutaneous INTERVENtion to Reduce Cardiovascular Events
NCT05333068· Diagram B.V.· Source
Active, not recruiting
Proact: A Study of REACT in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney Disease
NCT05099770· Phase 3· Prokidney· Source
Active, not recruiting
A Study to Evaluate the Efficacy and Safety of ONO-4538 in Combination With Ipilimumab and Chemotherapy in Chemotherapy-naïve Participants With HER2-negative Unresectable Advanced or Recurrent Gastric Cancer (Including Esophagogastric Junction Cancer)
NCT05144854· Phase 3· Ono Pharmaceutical Co., Ltd.· Source
Recruiting
Evaluate the Efficacy and Safety of FB825 in Adult With Allergic Asthma
NCT05008965· Phase 2· Oneness Biotech Co., Ltd.· Source
Contact: Shih-Lung Cheng
Active, not recruiting
A Phase 3 Study to Assess Efficacy and Safety of Tafasitamab Plus Lenalidomide and Rituximab Compared to Placebo Plus Lenalidomide and Rituximab in Patients With Relapsed/Refractory (R/R) Follicular Lymphoma or Marginal Zone Lymphoma.
NCT04680052· Phase 3· Incyte Corporation· Source
Active, not recruiting
Atrasentan in Patients With IgA Nephropathy
NCT04573478· Phase 3· Novartis Pharmaceuticals· Source
Recruiting
Sirolimus Coated Balloon Versus Standard Balloon for SFA and Popliteal Artery Disease
NCT04511234· Concept Medical Inc.· Source
Contact: Chen Jer-Shen, Dr.
Active, not recruiting
Ropeginterferon Alfa-2b (P1101) vs. Anagrelide in Essential Thrombocythemia Patients With Hydroxyurea Resistance or Intolerance
NCT04285086· Phase 3· PharmaEssentia· Source
Recruiting
SirolimUs CoaTed Balloon for The TrEatment of Below The Knee Arterial Disease
NCT04511247· Concept Medical Inc.· Source
Contact: Chen Jer-Shen, Dr.
Active, not recruiting
Observation of Clinical Routine Care for Heart Failure Patients Implanted With BIOTRONIK CRT Devices
NCT03366545· Biotronik SE & Co. KG· Source
Active, not recruiting
A Study in Ovarian Cancer Patients Evaluating Rucaparib and Nivolumab as Maintenance Treatment Following Response to Front-Line Platinum-Based Chemotherapy
NCT03522246· Phase 3· pharmaand GmbH· Source